BDBM259 (S)-4-[(4-Hydroxy-3-methyl-benzenesulfonylamino)-methyl]thiophene-2-carboxylic Acid [3-(2-Chloro-benz-ylsulfanyl)-1-ethyl-2-oxo-propyl]amide::5-{[(5-{[(2S)-1-carboxy-4-{[(2-chlorophenyl)methyl]sulfanyl}-3-oxobutan-2-yl]carbamoyl}thiophen-3-yl)methyl]sulfamoyl}-2-hydroxybenzoic acid::Heterocyclic deriv. 68b::Inhibitor 68b

SMILES OC(=O)C[C@H](NC(=O)c1cc(CNS(=O)(=O)c2ccc(O)c(c2)C(O)=O)cs1)C(=O)CSCc1ccccc1Cl

InChI Key InChIKey=UVOJEXKUDHCDHQ-IBGZPJMESA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 259   

TargetCaspase-3(Human)
Sunesis Pharmaceuticals

LigandPNGBDBM259((S)-4-[(4-Hydroxy-3-methyl-benzenesulfonylamino)-m...)
Affinity DataKi:  210nM ΔG°:  -9.10kcal/molepH: 7.4 T: 25°CAssay Description:The effectiveness of compounds against the activity of human recombinant caspase-1-8 was measured using fluorometric assays. Assays were carried out ...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed